Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Test Type

7.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Test Type, 2023-2032

7.1.1. Sandwich ELISA

7.1.1.1. Market Revenue and Forecast (2020-2032)

7.1.2. Indirect ELISA

7.1.2.1. Market Revenue and Forecast (2020-2032)

7.1.3. Multiple and Portable ELISA

7.1.3.1. Market Revenue and Forecast (2020-2032)

7.1.4. Competitive ELISA

7.1.4.1. Market Revenue and Forecast (2020-2032)

7.1.5. Others

7.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Application

8.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Application, 2023-2032

8.1.1. Immunology

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Inflammation

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Infectious diseases

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cancer

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Protein quantification

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Other Applications

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Test (2020-2032)

9.1.2. Market Revenue and Forecast, by Application (2020-2032)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.1.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Test (2020-2032)

9.2.2. Market Revenue and Forecast, by Application (2020-2032)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.2.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Test (2020-2032)

9.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Test (2020-2032)

9.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.3.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Test (2020-2032)

9.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Test (2020-2032)

9.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.4.2. Market Revenue and Forecast, by Application (2020-2032)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.4.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Test (2020-2032)

9.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Test (2020-2032)

9.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Test (2020-2032)

9.5.2. Market Revenue and Forecast, by Application (2020-2032)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Test (2020-2032)

9.5.3.2. Market Revenue and Forecast, by Application (2020-2032)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Test (2020-2032)

9.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

Chapter 10. Company Profiles

10.1. Thermo Fisher Scientific, Inc.

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. American Laboratory Products Company (ALPCO)

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Bio-Rad Laboratories, Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. BD

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. BioMérieux SA

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Ortho Clinical Diagnostics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. R&D Systems, Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. ZEUS Scientific, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms